C

GSK plc GSK

$49.46 -$0.05-0.10% NYSE
Recommendation
Dividend Power Score
Day's Range
$49.26$49.81
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
Access our Premium Ratings
Get Access

GSK Rating

Reward
Risk

GSK Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

GSK Company Overview

GSK plc is a global biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of medicines and vaccines. The company operates primarily within the pharmaceuticals and vaccines industries, serving governments, healthcare systems, and patients worldwide. Its core purpose is to prevent and treat disease across major therapeutic areas, including infectious diseases, HIV, respiratory and immunology, oncology, and specialty medicines.

The company traces its origins to the 18th century, evolving through multiple mergers and restructurings, most notably the formation of GlaxoSmithKline in 2000 and the subsequent demerger of its consumer healthcare business into Haleon plc in 2022. Following this separation, GSK became a more focused, innovation-driven biopharma company, emphasizing prescription medicines and vaccines with a strong science-led strategy.

Data compiled by narrative technology. May contain errors.
Sector
--
Industry
--

GSK Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

GSK Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

GSK Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

GSK Price History

Loading...
52-Week Range35% of range
Current
$49.46
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

GSK Valuation

Market Cap
Market Cap Rank
#322
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

GSK Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)

GSK Corporate Info

Phone Number
44 20 8047 5000
Address
79 New Oxford Street
London, WC1A 1DG
Country
Year Founded

GSK Filings

Filing Date
Tuesday, July 28, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Oct 26 and 30 (est)

GSK Headlines